Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #55672
advertisement
Sahel JA
17
Showing records 1 to 17 |
Display all abstracts from
Sahel JA
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Reboussin É
Journal of Neuroinflammation
2022; 19: 63
98517
Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy
Provansal M
Translational vision science & technology
2022; 11: 18
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Adrian J
Clinical and Experimental Ophthalmology
2022; 50: 420-428
98517
Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy
Marazova K
Translational vision science & technology
2022; 11: 18
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Buffault J
Journal of Neuroinflammation
2022; 19: 63
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Authié C; Lebrun J
Clinical and Experimental Ophthalmology
2022; 50: 420-428
98517
Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy
Sahel JA
Translational vision science & technology
2022; 11: 18
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Brignole-Baudouin F
Journal of Neuroinflammation
2022; 19: 63
98517
Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy
Picaud S
Translational vision science & technology
2022; 11: 18
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Réaux-Le Goazigo A
Journal of Neuroinflammation
2022; 19: 63
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Lombardi M; Zenouda A
Clinical and Experimental Ophthalmology
2022; 50: 420-428
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Riancho L; Olmiere C
Journal of Neuroinflammation
2022; 19: 63
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Gutman E
Clinical and Experimental Ophthalmology
2022; 50: 420-428
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Sahel JA
Journal of Neuroinflammation
2022; 19: 63
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Brasnu E; Hamard P
Clinical and Experimental Ophthalmology
2022; 50: 420-428
99009
Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model
Mélik Parsadaniantz S; Baudouin C
Journal of Neuroinflammation
2022; 19: 63
98901
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulator
Sahel JA; Baudouin C; Labbé A
Clinical and Experimental Ophthalmology
2022; 50: 420-428
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept